Pac Edge shares up 9% after positive results from medical trial

Pac Edge shares up 9% after positive results from medical trial
Sophie Boot
By Sophie Boot Nov. 14 (BusinessDesk) - Pacific Edge shares have rallied after the cancer diagnostics company announced positive results from a trial of its bladder test. The Dunedin-based company's Cxbladder Triage test, used to rule out patients with a low risk of bladder cancer, was evaluated in a large study of patients of Kaiser Permanente, a large not-for-profit healthcare provider in the US. The trial finding matched previously published findings which showed a sensitivity of 95.1 percent and a negative predictive value of 98.5...